Revvity, Inc. (NYSE:RVTY) Shares Sold by Cinctive Capital Management LP

Cinctive Capital Management LP decreased its position in shares of Revvity, Inc. (NYSE:RVTY) by 51.5% in the 4th quarter, HoldingsChannel.com reports. The fund owned 8,771 shares of the company’s stock after selling 9,297 shares during the quarter. Cinctive Capital Management LP’s holdings in Revvity were worth $979,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of the company. Assetmark Inc. increased its stake in shares of Revvity by 3,700.0% in the fourth quarter. Assetmark Inc. now owns 266 shares of the company’s stock valued at $30,000 after purchasing an additional 259 shares during the period. Millstone Evans Group LLC bought a new position in Revvity in the 4th quarter worth approximately $38,000. Continuum Advisory LLC increased its position in Revvity by 2,972.7% in the 3rd quarter. Continuum Advisory LLC now owns 338 shares of the company’s stock valued at $43,000 after acquiring an additional 327 shares during the period. MassMutual Private Wealth & Trust FSB raised its stake in Revvity by 55.9% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 385 shares of the company’s stock valued at $43,000 after acquiring an additional 138 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its position in Revvity by 33.5% during the 4th quarter. EverSource Wealth Advisors LLC now owns 522 shares of the company’s stock worth $58,000 after acquiring an additional 131 shares during the period. Institutional investors and hedge funds own 86.65% of the company’s stock.

Revvity Price Performance

RVTY opened at $100.76 on Friday. The company has a quick ratio of 3.03, a current ratio of 3.60 and a debt-to-equity ratio of 0.41. The company has a fifty day simple moving average of $113.75 and a 200 day simple moving average of $116.73. Revvity, Inc. has a 12 month low of $97.32 and a 12 month high of $129.50. The stock has a market cap of $12.11 billion, a P/E ratio of 45.59, a P/E/G ratio of 3.82 and a beta of 1.06.

Revvity (NYSE:RVTY) last released its earnings results on Friday, January 31st. The company reported $1.42 earnings per share for the quarter, beating analysts’ consensus estimates of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same period in the prior year, the company earned $1.25 earnings per share. On average, research analysts expect that Revvity, Inc. will post 4.94 EPS for the current year.

Revvity Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Friday, April 18th will be given a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.28%. The ex-dividend date of this dividend is Thursday, April 17th. Revvity’s payout ratio is presently 12.67%.

Insider Activity

In other news, insider Tajinder S. Vohra sold 5,492 shares of the stock in a transaction that occurred on Tuesday, January 7th. The stock was sold at an average price of $116.81, for a total value of $641,520.52. Following the completion of the sale, the insider now directly owns 19,652 shares of the company’s stock, valued at $2,295,550.12. This represents a 21.84 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Joel S. Goldberg sold 15,170 shares of the stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the completion of the sale, the insider now owns 33,400 shares of the company’s stock, valued at approximately $4,232,782. This represents a 31.23 % decrease in their position. The disclosure for this sale can be found here. 0.68% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

RVTY has been the topic of a number of recent analyst reports. Barclays boosted their price target on shares of Revvity from $135.00 to $140.00 and gave the stock an “overweight” rating in a research report on Monday, February 3rd. Raymond James reaffirmed an “outperform” rating and set a $145.00 price target (up from $140.00) on shares of Revvity in a research note on Monday, February 3rd. KeyCorp boosted their price objective on Revvity from $132.00 to $145.00 and gave the stock an “overweight” rating in a research note on Monday, February 3rd. Bank of America raised shares of Revvity from a “neutral” rating to a “buy” rating and set a $138.00 price target for the company in a report on Friday, December 13th. Finally, Sanford C. Bernstein lowered Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 target price on the stock. in a research report on Friday, January 10th. Four investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $136.25.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.